SOERGEL DAVID (Chief Medical Officer) received a stock award from MADRIGAL PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/6/2026ACC: 0001628280-26-015722
Officer· Chief Medical Officer
Since Mar 2026
+9.84K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.84K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.37K
Price / share
—
Trade value
—
% of position
58.0%
3/4/2026
7.54K→11.92K
Total
Net shares
+4.37K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | A · Award | +4.37K | — | — | 58.0% | 7.54K | 11.92K |
| Total | +4.37K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.47K shares
Shares
+5.47K
Strike price
434.80
Held after
5.47K
Exercisable
—
3/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.47K shares | 3/4/2026 | A · Award | +5.47K | 434.80 | — | 5.47K |